Skip to main content
OpenTrials
Completed

NCT Number: NCT05736120

Persons With Obesity (PwO) Exploratory Research

The purpose of this study is to understand the personal flow along the weight loss management journey. A range of variables will be addressed in a survey to explore the weight loss journey, barriers and management. Topics include weight loss strategies and challenges, HCP involvement, and perceptions towards weight loss medications.

Potential participants will be recruited using various online panels. Study participants will be recruited to participate in 2 types of qualitative research.

Phase I: Online bulletin boards (OBB) Phase II: Virtual focus groups (real-time)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Bengaluru, India

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 18 years at the time of signing informed consent.
  • Current body mass index (BMI) of 25 or greater
  • Not currently pregnant
  • Does not participate in intense fitness or body building program
  • Weight loss not through illness or injury
  • At least somewhat concerned about current weight
  • If no plans for weight loss in the next six months, has made at least 1 weight loss effort in last 5 years
  • Struggling with weight for at least 3 years

Exclusion criteria

  • Previous participation in this study. Participation is defined as having given informed consent in this study
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • Does not meet inclusion criteria.

Treatment and study plan

No treatment given

Other

No treatment given

Primary outcomes

  1. Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity.

    Time frame: 5 days (Phase 1)

    120-minute OBB discussion with numeric and open-ended response (Phase 1)

  2. Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity.

    Time frame: 1 day (Phase 2)

    90-minute focus group with open-ended response (Phase 2)

  3. Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey.

    Time frame: 5 days (Phase 1)

    120-minute OBB discussion with numeric and open-ended response (Phase 1)

  4. Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey.

    Time frame: 1 day (Phase 2)

    90-minute focus group with open-ended response (Phase 2)

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Official study title

Persons With Obesity (PwO) Exploratory Research - India

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 21, 2023
Registry last updated
May 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.